| A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease AU Zaidi, AK Glaros, S Lee, T Wang, R Bhojwani, E Morris, B Donohue, ... Orphanet journal of rare diseases 16, 1-12, 2021 | 21 | 2021 |
| Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor AK Glaros, R Razvi, N Shah, AU Zaidi Therapeutic advances in hematology 12, 20406207211001136, 2021 | 18 | 2021 |
| Neuropathic pain in sickle cell disease: measurement and management A Glaros, AM Brandow Hematology 2014, the American Society of Hematology Education Program Book …, 2020 | 7 | 2020 |
| Navigating a new terrain: how Twitter is changing hematologists AU Zaidi, AK Glaros, AC Weyand Blood Advances 5 (1), 277-278, 2021 | 5 | 2021 |
| Prophylactic hydroxyurea treatment is associated with improved cerebral hemodynamics as a surrogate marker of stroke risk in sickle cell disease: a retrospective comparative … BR Peine, MU Callaghan, JH Callaghan, AK Glaros Journal of Clinical Medicine 11 (12), 3491, 2022 | 4 | 2022 |
| Smaart Criz: Sickle Cell Mechanisms of Activation, Adhesion, Rheology, and Thrombosis (SMAART) in Response to P-Selectin Inhibition GG Guzzardo, M Chitlur, PC Hines, AU Zaidi, R Borhan, K Cinciarelli, ... Blood 142, 2528, 2023 | 2 | 2023 |
| A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study of Mitapivat in Patients with Sickle Cell Disease: RISE UP Phase 2 Results M Idowu, L Otieno, B Dumitriu, CLC Lobo, SL Thein, B Andemariam, ... Blood 142, 271, 2023 | 1 | 2023 |
| Targeting TRPV1 activity via high‐dose capsaicin in patients with sickle cell disease AK Glaros, MU Callaghan, WR Smith, AU Zaidi EJHaem 3 (3), 653-659, 2022 | 1 | 2022 |
| Real-world experience of patients with sickle cell disease treated with voxelotor: a multicenter, retrospective study B Andemariam, I Osunkwo, M Idowu, N Shah, R Drachtman, A Sharma, ... BRITISH JOURNAL OF HAEMATOLOGY 197, 134-135, 2022 | 1 | 2022 |
| Bone Fractures With and Without Sickle Cell Disease in the Pediatric Population A Wind, L Awad, D Merolla, A Glaros, A Bazzi, P Spencer, M Baske, ... | | 2024 |
| Modalités d’utilisation du voxelotor dans une étude multicentrique en vie réelle chez des patients drépanocytaires B Andemariam, M Idowu, N Shah, R Drachman, A Sharma, A Glaros, ... La Revue de Médecine Interne 44, A400, 2023 | | 2023 |
| Burden of Illness of Alpha-and Beta-Thalassemia: A Qualitative Study S Sheth, AK Glaros, M Martin, C Abel, WR Lenderking, S Morris, KS Gilroy, ... Blood 142, 7329, 2023 | | 2023 |
| PADRÕES DE USO DE VOXELOTOR EM UM ESTUDO MULTICÊNTRICO DO MUNDO REAL DE PACIENTES COM DOENÇA FALCIFORME B Andemariam, M Idowu, N Shah, R Drachtman, A Glaros, M Achebe, ... Hematology, Transfusion and Cell Therapy 45, S36-S37, 2023 | | 2023 |
| PB2516: ACTIGRAPHY IMPROVEMENT WITH VOXELOTOR (ACTIVE) STUDY: IMPACT OF VOXELOTOR ON PHYSICAL ACTIVITY, FATIGUE, AND SLEEP QUALITY N Shah, C Brown, B Andemariam, M Idowu, A Glaros, RM Cronin, ... HemaSphere 7 (S3), e707316d, 2023 | | 2023 |
| P1432: PATTERNS OF VOXELOTOR USE IN A MULTICENTER, REAL-WORLD STUDY OF PATIENTS WITH SICKLE CELL DISEASE B Andemariam, M Idowu, N Shah, R Drachtman, A Sharma, A Glaros, ... HemaSphere 7 (S3), e139426f, 2023 | | 2023 |
| PCR38 Contextualizing Health-State Utilities in Patients with Transfusion-Dependent eta-Thalassemia (TDT) K Gruppioni, TA Howell, J Jordan, LS Matza, J Boudreaux, SL Fritch, ... Value in Health 26 (6), S319, 2023 | | 2023 |
| Prévalence des ulcères de jambe et résultats dans une étude en vie réelle multicentrique rétrospective, menée auprès de patients drépanocytaires traités par voxelotor–Étude RETRO C Minniti, M Idowu, N Shah, R Drachtman, A Sharma, A Glaros, M Achebe, ... La Revue de Médecine Interne 44, A205-A206, 2023 | | 2023 |
| Étude ActIVe: impact de voxelotor sur la qualité du sommeil, l’activité physique et les indicateurs de résultats rapportés par les patients drépanocytaires N Shah, C Brown, B Andemariam, M Idowu, A Glaros, J Glassberg, ... La Revue de Médecine Interne 44, A179, 2023 | | 2023 |
| 5559749 A MULTICENTER, RETROSPECTIVE STUDY ON REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR B Andemariam, M Idowu, N Shah, R Drachtman, A Sharma, A Glaros, ... HemaSphere 7 (S1), 4, 2023 | | 2023 |
| Leg Ulcer Prevalence and Outcomes in a Real-World, Multicenter, Retrospective Study of Patients Treated with Voxelotor CP Minniti, HH Billett, D McMahon, M Idowu, N Shah, RA Drachtman, ... Blood 140 (Supplement 1), 8276-8277, 2022 | | 2022 |
